Tracey Ramsay
Vice-President and General Manager of AbbVie Canada
AbbVie celebrating 10 years of making a remarkable impact.
AbbVie’s 10th anniversary marks an important milestone. In Canada, over the past decade, the independent biopharmaceutical company has gone from ranking #14 to #3, launching 44 new medications or indications and more than doubling its employee base (now totalling more than 1,100 professionals). In the past three years, AbbVie Canada has also created more than 200 new jobs.
Investing in Canada’s life sciences sector
“Since 2013, we’ve been focused on investing in our people, building our capabilities, expanding our innovative pipeline, and diversifying our portfolio,” says Tracey Ramsay, Vice-President and General Manager of AbbVie Canada.
AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people’s lives. The company is driven by its compassion for people, commitment to innovation and inclusion, service to the community, and uncompromising integrity.
“We have a very robust early and late-stage pipeline,” says Ramsay. “We’re focused on unmet medical needs in our core areas — immunology, neuroscience, oncology, and eye care.”
Thanks to its dedication to innovation and research and development, AbbVie Canada will be launching 21 new medications or indications by the end of 2023.
Ensuring access to innovative medicines is also a priority for AbbVie Canada. “We believe patients deserve access to innovative therapies,” says Ramsay. “We need to find sustainable ways to balance our investment in research, our collective ability to provide access to these medications, and the cost of medications.”
As a leader in Canada’s life sciences sector, AbbVie is making a real difference in people’s lives.
Solving the tough challenges so we can raise the standard of treatment for everyone
Innovative medicines
44 new medicines and indications launched in Canada from 2013-2023
21 new medications and indications expected to launch in Canada by end of 2023
Economic Impact
1,100+ Canadian employees
200 jobs created since 2020
Research and Development (R&D)
94 active clinical trials
543+ Canadian trial sites
3,816+ Canadian patients
supporting active clinical trials
Learn more about AbbVie’s leadership in the space at
abbvie.ca, @abbviecanada.
